Carlsmed (CARL) Gross Profit (2024 - 2026)

Carlsmed (CARL) has 3 years of Gross Profit data on file, last reported at $12.4 million in Q1 2026.

• For the quarter ending Q1 2026, Gross Profit rose 62.72% year-over-year to $12.4 million; the trailing twelve-month figure through Mar 2026 stood at $42.8 million (up 78.31% YoY), and the FY2025 full-year result was $38.0 million, up 89.74% from the prior year.
• Gross Profit for Q1 2026 stood at $12.4 million, up from $11.6 million in the prior quarter.
• Across five years, Gross Profit topped out at $12.4 million in Q1 2026 and bottomed at $4.6 million in Q2 2024.
• The 3-year median for Gross Profit is $8.3 million (2025), against an average of $8.4 million.
• The widest annual swing landed in 2025, when Gross Profit soared 106.9%; it then soared 62.72% in 2026.
• A 3-year view of Gross Profit shows it stood at $7.0 million in 2024, then surged by 65.26% to $11.6 million in 2025, then rose by 7.04% to $12.4 million in 2026.
• The last three Gross Profit figures came in at $12.4 million (Q1 2026), $11.6 million (Q4 2025), and $9.9 million (Q3 2025), per Business Quant data.

Peer Comparison